Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-06-14

AUTHORS

Eliza M. Lauer, Jurik Mutter, Florian Scherer

ABSTRACT

Noninvasive disease monitoring and risk stratification by circulating tumor DNA (ctDNA) profiling has become a potential novel strategy for patient management in B-cell lymphoma. Emerging innovative therapeutic options and an unprecedented growth in our understanding of biological and molecular factors underlying lymphoma heterogeneity have fundamentally increased the need for precision-based tools facilitating personalized and accurate disease profiling and quantification. By capturing the entire mutational landscape of tumors, ctDNA assessment has some decisive advantages over conventional tissue biopsies, which usually target only one single tumor site. Due to its non- or minimal-invasive nature, serial and repeated ctDNA profiling provides a real-time picture of the genetic composition and facilitates quantification of tumor burden any time during the course of the disease. In this review, we present a comprehensive overview of technologies used for ctDNA detection and genotyping in B-cell lymphoma, focusing on pre-analytical and technical requirements, the advantages and limitations of various approaches, and highlight recent advances around improving sensitivity and suppressing technical errors. We broadly review potential applications of ctDNA in clinical practice and for translational research by describing how ctDNA might enhance lymphoma subtype classification, treatment response assessment, outcome prediction, and monitoring of measurable residual disease. We finally discuss how ctDNA could be implemented in prospective clinical trials as a novel surrogate endpoint and be utilized as a decision-making tool to guide lymphoma treatment in the future. More... »

PAGES

2151-2164

References to SciGraph publications

  • 2000-02. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling in NATURE
  • 2006-10. Correlation of diagnostic yield of stereotactic brain biopsy with number of biopsy bits and site of the lesion in BRAIN TUMOR PATHOLOGY
  • 2015-07-20. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma in NATURE MEDICINE
  • 2020-02-28. Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors in GENOME MEDICINE
  • 2017-02-24. Liquid biopsies come of age: towards implementation of circulating tumour DNA in NATURE REVIEWS CANCER
  • 2020-06-22. Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes in NATURE MEDICINE
  • 2021-04-05. Diffuse large B-cell lymphoma: new targets and novel therapies in BLOOD CANCER JOURNAL
  • 2022-03-31. Inferring gene expression from cell-free DNA fragmentation profiles in NATURE BIOTECHNOLOGY
  • 2016-03-28. Integrated digital error suppression for improved detection of circulating tumor DNA in NATURE BIOTECHNOLOGY
  • 2020-10-07. Liquid biopsy approaches for pleural effusion in lung cancer patients in MOLECULAR BIOLOGY REPORTS
  • 2014-04-06. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage in NATURE MEDICINE
  • 2019-11-25. High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants in NATURE MEDICINE
  • 2022-04-14. Using cell-free DNA to infer gene expression in NATURE REVIEWS GENETICS
  • 2020-03-25. Integrating genomic features for non-invasive early lung cancer detection in NATURE
  • 2019-08-20. Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma in LEUKEMIA
  • 2019-08-28. MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial in LEUKEMIA
  • 2018-11-19. Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma in NATURE MEDICINE
  • 2018-04-30. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes in NATURE MEDICINE
  • 2001-07. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas in NATURE
  • 2018-08-01. Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort in BLOOD CANCER JOURNAL
  • 2019-03-01. Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas in BMC CANCER
  • 2014-10-09. Detecting ultralow-frequency mutations by Duplex Sequencing in NATURE PROTOCOLS
  • 2014-06-06. Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2020-01-21. Multi-Target Stool DNA Testing for Colorectal Cancer Screening: Emerging Learning on Real-world Performance in CURRENT TREATMENT OPTIONS IN GASTROENTEROLOGY
  • 2019-10-12. Capturing Tumor Heterogeneity and Clonal Evolution by Circulating Tumor DNA Profiling in TUMOR LIQUID BIOPSIES
  • 2021-07-22. Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA in NATURE BIOTECHNOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/s41375-022-01618-w

    DOI

    http://dx.doi.org/10.1038/s41375-022-01618-w

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1148649866

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/35701522


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biomarkers, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Circulating Tumor DNA", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lymphoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lymphoma, B-Cell", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasm, Residual", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prospective Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Translational Research, Biomedical", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Medicine I, Medical Center \u2013 University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany", 
              "id": "http://www.grid.ac/institutes/grid.7708.8", 
              "name": [
                "Department of Medicine I, Medical Center \u2013 University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lauer", 
            "givenName": "Eliza M.", 
            "id": "sg:person.01155526025.99", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155526025.99"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Faculty of Biology, University of Freiburg, Freiburg, Germany", 
              "id": "http://www.grid.ac/institutes/grid.5963.9", 
              "name": [
                "Department of Medicine I, Medical Center \u2013 University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany", 
                "Faculty of Biology, University of Freiburg, Freiburg, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mutter", 
            "givenName": "Jurik", 
            "id": "sg:person.07502052221.21", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07502052221.21"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "German Cancer Consortium (DKTK) partner site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany", 
              "id": "http://www.grid.ac/institutes/grid.7497.d", 
              "name": [
                "Department of Medicine I, Medical Center \u2013 University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany", 
                "German Cancer Consortium (DKTK) partner site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Scherer", 
            "givenName": "Florian", 
            "id": "sg:person.01123455235.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123455235.17"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1186/s12885-019-5394-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1112474132", 
              "https://doi.org/10.1186/s12885-019-5394-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41587-021-00981-w", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1139861764", 
              "https://doi.org/10.1038/s41587-021-00981-w"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm.3519", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051843226", 
              "https://doi.org/10.1038/nm.3519"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/35085588", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013839107", 
              "https://doi.org/10.1038/35085588"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41587-022-01222-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1146773403", 
              "https://doi.org/10.1038/s41587-022-01222-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41591-018-0016-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1103688410", 
              "https://doi.org/10.1038/s41591-018-0016-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41586-020-2140-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1125893925", 
              "https://doi.org/10.1038/s41586-020-2140-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41591-020-0933-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1128664801", 
              "https://doi.org/10.1038/s41591-020-0933-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-3-030-26439-0_11", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1121685833", 
              "https://doi.org/10.1007/978-3-030-26439-0_11"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41591-019-0652-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1122864170", 
              "https://doi.org/10.1038/s41591-019-0652-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41408-021-00456-w", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1136924728", 
              "https://doi.org/10.1038/s41408-021-00456-w"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41576-022-00489-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1147109718", 
              "https://doi.org/10.1038/s41576-022-00489-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm.3884", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027170130", 
              "https://doi.org/10.1038/nm.3884"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11938-020-00271-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1124213830", 
              "https://doi.org/10.1007/s11938-020-00271-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc.2017.7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1083863116", 
              "https://doi.org/10.1038/nrc.2017.7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41408-018-0111-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1105940425", 
              "https://doi.org/10.1038/s41408-018-0111-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-014-2822-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003196884", 
              "https://doi.org/10.1007/s00259-014-2822-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/35000501", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010898206", 
              "https://doi.org/10.1038/35000501"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11033-020-05869-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1131501845", 
              "https://doi.org/10.1007/s11033-020-05869-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.3520", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042966935", 
              "https://doi.org/10.1038/nbt.3520"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41375-019-0541-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1120407081", 
              "https://doi.org/10.1038/s41375-019-0541-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41591-018-0243-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1109946036", 
              "https://doi.org/10.1038/s41591-018-0243-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41375-019-0559-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1120639184", 
              "https://doi.org/10.1038/s41375-019-0559-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10014-006-0204-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047829980", 
              "https://doi.org/10.1007/s10014-006-0204-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13073-020-00723-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1125153957", 
              "https://doi.org/10.1186/s13073-020-00723-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nprot.2014.170", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012801607", 
              "https://doi.org/10.1038/nprot.2014.170"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2022-06-14", 
        "datePublishedReg": "2022-06-14", 
        "description": "Noninvasive disease monitoring and risk stratification by circulating tumor DNA (ctDNA) profiling has become a potential novel strategy for patient management in B-cell lymphoma. Emerging innovative therapeutic options and an unprecedented growth in our understanding of biological and molecular factors underlying lymphoma heterogeneity have fundamentally increased the need for precision-based tools facilitating personalized and accurate disease profiling and quantification. By capturing the entire mutational landscape of tumors, ctDNA assessment has some decisive advantages over conventional tissue biopsies, which usually target only one single tumor site. Due to its non- or minimal-invasive nature, serial and repeated ctDNA profiling provides a real-time picture of the genetic composition and facilitates quantification of tumor burden any time during the course of the disease. In this review, we present a comprehensive overview of technologies used for ctDNA detection and genotyping in B-cell lymphoma, focusing on pre-analytical and technical requirements, the advantages and limitations of various approaches, and highlight recent advances around improving sensitivity and suppressing technical errors. We broadly review potential applications of ctDNA in clinical practice and for translational research by describing how ctDNA might enhance lymphoma subtype classification, treatment response assessment, outcome prediction, and monitoring of measurable residual disease. We finally discuss how ctDNA could be implemented in prospective clinical trials as a novel surrogate endpoint and be utilized as a decision-making tool to guide lymphoma treatment in the future.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/s41375-022-01618-w", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1097065", 
            "issn": [
              "0887-6924", 
              "1476-5551"
            ], 
            "name": "Leukemia", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "9", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "36"
          }
        ], 
        "keywords": [
          "B-cell lymphoma", 
          "novel surrogate endpoints", 
          "translational research", 
          "prospective clinical trials", 
          "innovative therapeutic options", 
          "measurable residual disease", 
          "single tumor site", 
          "Tumor DNA Profiling", 
          "noninvasive disease monitoring", 
          "potential novel strategy", 
          "treatment response assessment", 
          "minimal invasive nature", 
          "conventional tissue biopsy", 
          "risk stratification", 
          "tumor burden", 
          "therapeutic options", 
          "residual disease", 
          "lymphoma treatment", 
          "ctDNA profiling", 
          "clinical trials", 
          "patient management", 
          "ctDNA assessment", 
          "surrogate endpoints", 
          "response assessment", 
          "tissue biopsies", 
          "clinical practice", 
          "tumor site", 
          "tumor DNA", 
          "lymphoma", 
          "ctDNA detection", 
          "subtype classification", 
          "disease monitoring", 
          "disease profiling", 
          "clinical application", 
          "mutational landscape", 
          "molecular factors", 
          "technical errors", 
          "disease", 
          "novel strategy", 
          "biopsy", 
          "technical advances", 
          "tumors", 
          "trials", 
          "endpoint", 
          "assessment", 
          "profiling", 
          "treatment", 
          "burden", 
          "recent advances", 
          "review", 
          "options", 
          "comprehensive overview", 
          "stratification", 
          "monitoring", 
          "advances", 
          "course", 
          "management", 
          "factors", 
          "quantification", 
          "sensitivity", 
          "decision-making tool", 
          "heterogeneity", 
          "need", 
          "DNA", 
          "practice", 
          "tool", 
          "strategies", 
          "sites", 
          "detection", 
          "research", 
          "classification", 
          "DNA profiling", 
          "time", 
          "real-time picture", 
          "overview", 
          "growth", 
          "limitations", 
          "understanding", 
          "genetic composition", 
          "picture", 
          "future", 
          "advantages", 
          "approach", 
          "decisive advantage", 
          "perspective", 
          "technical requirements", 
          "nature", 
          "requirements", 
          "potential applications", 
          "composition", 
          "applications", 
          "prediction", 
          "unprecedented growth", 
          "error", 
          "technology", 
          "landscape"
        ], 
        "name": "Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research", 
        "pagination": "2151-2164", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1148649866"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/s41375-022-01618-w"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "35701522"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/s41375-022-01618-w", 
          "https://app.dimensions.ai/details/publication/pub.1148649866"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:50", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_929.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/s41375-022-01618-w"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41375-022-01618-w'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41375-022-01618-w'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41375-022-01618-w'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41375-022-01618-w'


     

    This table displays all metadata directly associated to this object as RDF triples.

    315 TRIPLES      21 PREDICATES      155 URIs      121 LITERALS      15 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/s41375-022-01618-w schema:about N0296ef76c39f4c4bb84e865a7bbf6e20
    2 N038088ddde784372b8048de7605383f9
    3 N43d1698022394cb4ab0b163ad21a4a86
    4 N4db1c2a5659447c88221ef5e12ba65cf
    5 N5e575da231214d93b6cc49de2dedf5e2
    6 N6bea4ff63e934f4b9f53b3c8ec5f85e6
    7 Nb870a1a6cf9f46f18befb596322185e8
    8 Nd1f8cee3f73c435e9250ba505855c130
    9 anzsrc-for:11
    10 anzsrc-for:1112
    11 schema:author N974e073b1d164e37998dbcd01bc23102
    12 schema:citation sg:pub.10.1007/978-3-030-26439-0_11
    13 sg:pub.10.1007/s00259-014-2822-7
    14 sg:pub.10.1007/s10014-006-0204-y
    15 sg:pub.10.1007/s11033-020-05869-7
    16 sg:pub.10.1007/s11938-020-00271-5
    17 sg:pub.10.1038/35000501
    18 sg:pub.10.1038/35085588
    19 sg:pub.10.1038/nbt.3520
    20 sg:pub.10.1038/nm.3519
    21 sg:pub.10.1038/nm.3884
    22 sg:pub.10.1038/nprot.2014.170
    23 sg:pub.10.1038/nrc.2017.7
    24 sg:pub.10.1038/s41375-019-0541-6
    25 sg:pub.10.1038/s41375-019-0559-9
    26 sg:pub.10.1038/s41408-018-0111-6
    27 sg:pub.10.1038/s41408-021-00456-w
    28 sg:pub.10.1038/s41576-022-00489-2
    29 sg:pub.10.1038/s41586-020-2140-0
    30 sg:pub.10.1038/s41587-021-00981-w
    31 sg:pub.10.1038/s41587-022-01222-4
    32 sg:pub.10.1038/s41591-018-0016-8
    33 sg:pub.10.1038/s41591-018-0243-z
    34 sg:pub.10.1038/s41591-019-0652-7
    35 sg:pub.10.1038/s41591-020-0933-1
    36 sg:pub.10.1186/s12885-019-5394-x
    37 sg:pub.10.1186/s13073-020-00723-8
    38 schema:datePublished 2022-06-14
    39 schema:datePublishedReg 2022-06-14
    40 schema:description Noninvasive disease monitoring and risk stratification by circulating tumor DNA (ctDNA) profiling has become a potential novel strategy for patient management in B-cell lymphoma. Emerging innovative therapeutic options and an unprecedented growth in our understanding of biological and molecular factors underlying lymphoma heterogeneity have fundamentally increased the need for precision-based tools facilitating personalized and accurate disease profiling and quantification. By capturing the entire mutational landscape of tumors, ctDNA assessment has some decisive advantages over conventional tissue biopsies, which usually target only one single tumor site. Due to its non- or minimal-invasive nature, serial and repeated ctDNA profiling provides a real-time picture of the genetic composition and facilitates quantification of tumor burden any time during the course of the disease. In this review, we present a comprehensive overview of technologies used for ctDNA detection and genotyping in B-cell lymphoma, focusing on pre-analytical and technical requirements, the advantages and limitations of various approaches, and highlight recent advances around improving sensitivity and suppressing technical errors. We broadly review potential applications of ctDNA in clinical practice and for translational research by describing how ctDNA might enhance lymphoma subtype classification, treatment response assessment, outcome prediction, and monitoring of measurable residual disease. We finally discuss how ctDNA could be implemented in prospective clinical trials as a novel surrogate endpoint and be utilized as a decision-making tool to guide lymphoma treatment in the future.
    41 schema:genre article
    42 schema:isAccessibleForFree true
    43 schema:isPartOf N02b3faf8991e4250a7cf9b8d75f19fed
    44 N0688ebce4de1433bba2b4bb4cc1f2911
    45 sg:journal.1097065
    46 schema:keywords B-cell lymphoma
    47 DNA
    48 DNA profiling
    49 Tumor DNA Profiling
    50 advances
    51 advantages
    52 applications
    53 approach
    54 assessment
    55 biopsy
    56 burden
    57 classification
    58 clinical application
    59 clinical practice
    60 clinical trials
    61 composition
    62 comprehensive overview
    63 conventional tissue biopsy
    64 course
    65 ctDNA assessment
    66 ctDNA detection
    67 ctDNA profiling
    68 decision-making tool
    69 decisive advantage
    70 detection
    71 disease
    72 disease monitoring
    73 disease profiling
    74 endpoint
    75 error
    76 factors
    77 future
    78 genetic composition
    79 growth
    80 heterogeneity
    81 innovative therapeutic options
    82 landscape
    83 limitations
    84 lymphoma
    85 lymphoma treatment
    86 management
    87 measurable residual disease
    88 minimal invasive nature
    89 molecular factors
    90 monitoring
    91 mutational landscape
    92 nature
    93 need
    94 noninvasive disease monitoring
    95 novel strategy
    96 novel surrogate endpoints
    97 options
    98 overview
    99 patient management
    100 perspective
    101 picture
    102 potential applications
    103 potential novel strategy
    104 practice
    105 prediction
    106 profiling
    107 prospective clinical trials
    108 quantification
    109 real-time picture
    110 recent advances
    111 requirements
    112 research
    113 residual disease
    114 response assessment
    115 review
    116 risk stratification
    117 sensitivity
    118 single tumor site
    119 sites
    120 strategies
    121 stratification
    122 subtype classification
    123 surrogate endpoints
    124 technical advances
    125 technical errors
    126 technical requirements
    127 technology
    128 therapeutic options
    129 time
    130 tissue biopsies
    131 tool
    132 translational research
    133 treatment
    134 treatment response assessment
    135 trials
    136 tumor DNA
    137 tumor burden
    138 tumor site
    139 tumors
    140 understanding
    141 unprecedented growth
    142 schema:name Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research
    143 schema:pagination 2151-2164
    144 schema:productId N0297a7d299c34ec5a50af2d0436a4fc9
    145 N2dc03d5ee4184eb8a438e294605184fe
    146 N691d1bfababd40ddae9518f3d7767de0
    147 schema:sameAs https://app.dimensions.ai/details/publication/pub.1148649866
    148 https://doi.org/10.1038/s41375-022-01618-w
    149 schema:sdDatePublished 2022-10-01T06:50
    150 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    151 schema:sdPublisher N15df291c13b644d8bd04c35f1be7740c
    152 schema:url https://doi.org/10.1038/s41375-022-01618-w
    153 sgo:license sg:explorer/license/
    154 sgo:sdDataset articles
    155 rdf:type schema:ScholarlyArticle
    156 N0296ef76c39f4c4bb84e865a7bbf6e20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Lymphoma
    158 rdf:type schema:DefinedTerm
    159 N0297a7d299c34ec5a50af2d0436a4fc9 schema:name pubmed_id
    160 schema:value 35701522
    161 rdf:type schema:PropertyValue
    162 N02b3faf8991e4250a7cf9b8d75f19fed schema:issueNumber 9
    163 rdf:type schema:PublicationIssue
    164 N038088ddde784372b8048de7605383f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Humans
    166 rdf:type schema:DefinedTerm
    167 N0688ebce4de1433bba2b4bb4cc1f2911 schema:volumeNumber 36
    168 rdf:type schema:PublicationVolume
    169 N15df291c13b644d8bd04c35f1be7740c schema:name Springer Nature - SN SciGraph project
    170 rdf:type schema:Organization
    171 N2dc03d5ee4184eb8a438e294605184fe schema:name dimensions_id
    172 schema:value pub.1148649866
    173 rdf:type schema:PropertyValue
    174 N3c5ff75c8d474d81af54f3ded1ab9104 rdf:first sg:person.07502052221.21
    175 rdf:rest N62322c2df68e4db9ad3245c33016f087
    176 N43d1698022394cb4ab0b163ad21a4a86 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    177 schema:name Biomarkers, Tumor
    178 rdf:type schema:DefinedTerm
    179 N4db1c2a5659447c88221ef5e12ba65cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    180 schema:name Circulating Tumor DNA
    181 rdf:type schema:DefinedTerm
    182 N5e575da231214d93b6cc49de2dedf5e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    183 schema:name Prospective Studies
    184 rdf:type schema:DefinedTerm
    185 N62322c2df68e4db9ad3245c33016f087 rdf:first sg:person.01123455235.17
    186 rdf:rest rdf:nil
    187 N691d1bfababd40ddae9518f3d7767de0 schema:name doi
    188 schema:value 10.1038/s41375-022-01618-w
    189 rdf:type schema:PropertyValue
    190 N6bea4ff63e934f4b9f53b3c8ec5f85e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    191 schema:name Translational Research, Biomedical
    192 rdf:type schema:DefinedTerm
    193 N974e073b1d164e37998dbcd01bc23102 rdf:first sg:person.01155526025.99
    194 rdf:rest N3c5ff75c8d474d81af54f3ded1ab9104
    195 Nb870a1a6cf9f46f18befb596322185e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    196 schema:name Neoplasm, Residual
    197 rdf:type schema:DefinedTerm
    198 Nd1f8cee3f73c435e9250ba505855c130 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    199 schema:name Lymphoma, B-Cell
    200 rdf:type schema:DefinedTerm
    201 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    202 schema:name Medical and Health Sciences
    203 rdf:type schema:DefinedTerm
    204 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    205 schema:name Oncology and Carcinogenesis
    206 rdf:type schema:DefinedTerm
    207 sg:journal.1097065 schema:issn 0887-6924
    208 1476-5551
    209 schema:name Leukemia
    210 schema:publisher Springer Nature
    211 rdf:type schema:Periodical
    212 sg:person.01123455235.17 schema:affiliation grid-institutes:grid.7497.d
    213 schema:familyName Scherer
    214 schema:givenName Florian
    215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123455235.17
    216 rdf:type schema:Person
    217 sg:person.01155526025.99 schema:affiliation grid-institutes:grid.7708.8
    218 schema:familyName Lauer
    219 schema:givenName Eliza M.
    220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155526025.99
    221 rdf:type schema:Person
    222 sg:person.07502052221.21 schema:affiliation grid-institutes:grid.5963.9
    223 schema:familyName Mutter
    224 schema:givenName Jurik
    225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07502052221.21
    226 rdf:type schema:Person
    227 sg:pub.10.1007/978-3-030-26439-0_11 schema:sameAs https://app.dimensions.ai/details/publication/pub.1121685833
    228 https://doi.org/10.1007/978-3-030-26439-0_11
    229 rdf:type schema:CreativeWork
    230 sg:pub.10.1007/s00259-014-2822-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003196884
    231 https://doi.org/10.1007/s00259-014-2822-7
    232 rdf:type schema:CreativeWork
    233 sg:pub.10.1007/s10014-006-0204-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1047829980
    234 https://doi.org/10.1007/s10014-006-0204-y
    235 rdf:type schema:CreativeWork
    236 sg:pub.10.1007/s11033-020-05869-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1131501845
    237 https://doi.org/10.1007/s11033-020-05869-7
    238 rdf:type schema:CreativeWork
    239 sg:pub.10.1007/s11938-020-00271-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1124213830
    240 https://doi.org/10.1007/s11938-020-00271-5
    241 rdf:type schema:CreativeWork
    242 sg:pub.10.1038/35000501 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010898206
    243 https://doi.org/10.1038/35000501
    244 rdf:type schema:CreativeWork
    245 sg:pub.10.1038/35085588 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013839107
    246 https://doi.org/10.1038/35085588
    247 rdf:type schema:CreativeWork
    248 sg:pub.10.1038/nbt.3520 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042966935
    249 https://doi.org/10.1038/nbt.3520
    250 rdf:type schema:CreativeWork
    251 sg:pub.10.1038/nm.3519 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051843226
    252 https://doi.org/10.1038/nm.3519
    253 rdf:type schema:CreativeWork
    254 sg:pub.10.1038/nm.3884 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027170130
    255 https://doi.org/10.1038/nm.3884
    256 rdf:type schema:CreativeWork
    257 sg:pub.10.1038/nprot.2014.170 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012801607
    258 https://doi.org/10.1038/nprot.2014.170
    259 rdf:type schema:CreativeWork
    260 sg:pub.10.1038/nrc.2017.7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083863116
    261 https://doi.org/10.1038/nrc.2017.7
    262 rdf:type schema:CreativeWork
    263 sg:pub.10.1038/s41375-019-0541-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1120407081
    264 https://doi.org/10.1038/s41375-019-0541-6
    265 rdf:type schema:CreativeWork
    266 sg:pub.10.1038/s41375-019-0559-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1120639184
    267 https://doi.org/10.1038/s41375-019-0559-9
    268 rdf:type schema:CreativeWork
    269 sg:pub.10.1038/s41408-018-0111-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105940425
    270 https://doi.org/10.1038/s41408-018-0111-6
    271 rdf:type schema:CreativeWork
    272 sg:pub.10.1038/s41408-021-00456-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1136924728
    273 https://doi.org/10.1038/s41408-021-00456-w
    274 rdf:type schema:CreativeWork
    275 sg:pub.10.1038/s41576-022-00489-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1147109718
    276 https://doi.org/10.1038/s41576-022-00489-2
    277 rdf:type schema:CreativeWork
    278 sg:pub.10.1038/s41586-020-2140-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1125893925
    279 https://doi.org/10.1038/s41586-020-2140-0
    280 rdf:type schema:CreativeWork
    281 sg:pub.10.1038/s41587-021-00981-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1139861764
    282 https://doi.org/10.1038/s41587-021-00981-w
    283 rdf:type schema:CreativeWork
    284 sg:pub.10.1038/s41587-022-01222-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1146773403
    285 https://doi.org/10.1038/s41587-022-01222-4
    286 rdf:type schema:CreativeWork
    287 sg:pub.10.1038/s41591-018-0016-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103688410
    288 https://doi.org/10.1038/s41591-018-0016-8
    289 rdf:type schema:CreativeWork
    290 sg:pub.10.1038/s41591-018-0243-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1109946036
    291 https://doi.org/10.1038/s41591-018-0243-z
    292 rdf:type schema:CreativeWork
    293 sg:pub.10.1038/s41591-019-0652-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1122864170
    294 https://doi.org/10.1038/s41591-019-0652-7
    295 rdf:type schema:CreativeWork
    296 sg:pub.10.1038/s41591-020-0933-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1128664801
    297 https://doi.org/10.1038/s41591-020-0933-1
    298 rdf:type schema:CreativeWork
    299 sg:pub.10.1186/s12885-019-5394-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1112474132
    300 https://doi.org/10.1186/s12885-019-5394-x
    301 rdf:type schema:CreativeWork
    302 sg:pub.10.1186/s13073-020-00723-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1125153957
    303 https://doi.org/10.1186/s13073-020-00723-8
    304 rdf:type schema:CreativeWork
    305 grid-institutes:grid.5963.9 schema:alternateName Faculty of Biology, University of Freiburg, Freiburg, Germany
    306 schema:name Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
    307 Faculty of Biology, University of Freiburg, Freiburg, Germany
    308 rdf:type schema:Organization
    309 grid-institutes:grid.7497.d schema:alternateName German Cancer Consortium (DKTK) partner site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany
    310 schema:name Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
    311 German Cancer Consortium (DKTK) partner site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany
    312 rdf:type schema:Organization
    313 grid-institutes:grid.7708.8 schema:alternateName Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
    314 schema:name Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
    315 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...